Cerebral palsy: Causes, pathways, and the role of genetic variants.

[1]  Caroline A Crowther,et al.  Magnesium sulphate at 30 to 34 weeks’ gestational age: neuroprotection trial (MAGENTA) - study protocol , 2013, BMC Pregnancy and Childbirth.

[2]  S. Oddie,et al.  Antenatal magnesium sulfate: Neuro-protection for preterm infants , 2015, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[3]  J. Gécz,et al.  Cerebral palsy: causes, pathways, and the role of genetic variants. , 2015, American journal of obstetrics and gynecology.